These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 25757913

  • 21. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 22. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene.
    Baghai TC, Schule C, Zwanzger P, Minov C, Zill P, Ella R, Eser D, Oezer S, Bondy B, Rupprecht R.
    Neurosci Lett; 2002 Aug 16; 328(3):299-303. PubMed ID: 12147330
    [Abstract] [Full Text] [Related]

  • 23. Plasma corticosterone, dexamethasone (DEX) suppression and DEX/CRH tests in a rat model of genetic vulnerability to depression.
    Steimer T, Python A, Schulz PE, Aubry JM.
    Psychoneuroendocrinology; 2007 Jun 16; 32(5):575-9. PubMed ID: 17512120
    [Abstract] [Full Text] [Related]

  • 24. Combined dexamethasone suppression-corticotropin-releasing hormone stimulation test in studies of depression, alcoholism, and suicidal behavior.
    Sher L.
    ScientificWorldJournal; 2006 Oct 31; 6():1398-404. PubMed ID: 17086345
    [Abstract] [Full Text] [Related]

  • 25. ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.
    Lee EE, Nieman LK, Martinez PE, Harsh VL, Rubinow DR, Schmidt PJ.
    J Clin Endocrinol Metab; 2012 Jun 31; 97(6):1887-96. PubMed ID: 22466349
    [Abstract] [Full Text] [Related]

  • 26. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
    Menke A, Arloth J, Best J, Namendorf C, Gerlach T, Czamara D, Lucae S, Dunlop BW, Crowe TM, Garlow SJ, Nemeroff CB, Ritchie JC, Craighead WE, Mayberg HS, Rex-Haffner M, Binder EB, Uhr M.
    Psychoneuroendocrinology; 2016 Jul 31; 69():161-71. PubMed ID: 27107207
    [Abstract] [Full Text] [Related]

  • 27. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
    Kudielka BM, Schmidt-Reinwald AK, Hellhammer DH, Kirschbaum C.
    Neuroendocrinology; 1999 Dec 31; 70(6):422-30. PubMed ID: 10657735
    [Abstract] [Full Text] [Related]

  • 28. Enhanced suppression of adrenocorticotropic hormone and cortisol responses to hypothalamic-pituitary-adrenal function and thyrotropin-releasing hormone tests after stressful life events in patients with major depressive disorder.
    Hikichi T, Akiyoshi J, Ichioka S, Tanaka Y, Tsuru J, Goto S, Matsushita H, Hanada H, Isogawa K, Nagayama H.
    Neuropsychobiology; 2007 Dec 31; 55(1):21-7. PubMed ID: 17556849
    [Abstract] [Full Text] [Related]

  • 29. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder.
    Watson S, Gallagher P, Ritchie JC, Ferrier IN, Young AH.
    Br J Psychiatry; 2004 Jun 31; 184():496-502. PubMed ID: 15172943
    [Abstract] [Full Text] [Related]

  • 30. Abnormalities of the hypothalamic-pituitary-adrenal axis in nondepressed women with abdominal obesity and relations with insulin resistance: evidence for a central and a peripheral alteration.
    Vicennati V, Pasquali R.
    J Clin Endocrinol Metab; 2000 Nov 31; 85(11):4093-8. PubMed ID: 11095438
    [Abstract] [Full Text] [Related]

  • 31. Relationships between psychological distress, coping styles, and HPA axis reactivity in healthy adults.
    Hori H, Ozeki Y, Teraishi T, Matsuo J, Kawamoto Y, Kinoshita Y, Suto S, Terada S, Higuchi T, Kunugi H.
    J Psychiatr Res; 2010 Oct 31; 44(14):865-73. PubMed ID: 20334880
    [Abstract] [Full Text] [Related]

  • 32. Central noradrenaline transporter availability is linked with HPA axis responsiveness and copeptin in human obesity and non-obese controls.
    Schinke C, Hesse S, Rullmann M, Becker GA, Luthardt J, Zientek F, Patt M, Stoppe M, Schmidt E, Meyer K, Meyer PM, Orthgieß J, Blüher M, Kratzsch J, Ding YS, Then Bergh F, Sabri O.
    Stress; 2019 Jan 31; 22(1):93-102. PubMed ID: 30369292
    [Abstract] [Full Text] [Related]

  • 33. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
    Neuropsychopharmacology; 2003 Dec 31; 28(12):2169-78. PubMed ID: 12931142
    [Abstract] [Full Text] [Related]

  • 34. Dex/CRH-test response and sleep in depressed patients and healthy controls with and without vulnerability for affective disorders.
    Friess E, Schmid D, Modell S, Brunner H, Lauer CJ, Holsboer F, Ising M.
    J Psychiatr Res; 2008 Oct 31; 42(14):1154-62. PubMed ID: 18281062
    [Abstract] [Full Text] [Related]

  • 35. Associations between neuroendocrine responses to the Insulin Tolerance Test and patient characteristics in chronic fatigue syndrome.
    Gaab J, Engert V, Heitz V, Schad T, Schürmeyer TH, Ehlert U.
    J Psychosom Res; 2004 Apr 31; 56(4):419-24. PubMed ID: 15094026
    [Abstract] [Full Text] [Related]

  • 36. High neuroticism and depressive temperament are associated with dysfunctional regulation of the hypothalamic-pituitary-adrenocortical system in healthy volunteers.
    Zobel A, Barkow K, Schulze-Rauschenbach S, Von Widdern O, Metten M, Pfeiffer U, Schnell S, Wagner M, Maier W.
    Acta Psychiatr Scand; 2004 May 31; 109(5):392-9. PubMed ID: 15049775
    [Abstract] [Full Text] [Related]

  • 37. Hypothalamic-pituitary-adrenal axis activity and cognition in major depression: The role of remission status.
    Salvat-Pujol N, Labad J, Urretavizcaya M, de Arriba-Arnau A, Segalàs C, Real E, Ferrer A, Crespo JM, Jiménez-Murcia S, Soriano-Mas C, Menchón JM, Soria V.
    Psychoneuroendocrinology; 2017 Feb 31; 76():38-48. PubMed ID: 27883963
    [Abstract] [Full Text] [Related]

  • 38. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jul 31; 186(4):601-11. PubMed ID: 16758243
    [Abstract] [Full Text] [Related]

  • 39. The prevalence of impaired glucose regulation in psychiatric patients with sleep disorders and its relationship with altered hypothalamopituitary-adrenal and hypothalamopituitary-thyroid axis activity.
    Li J, Sun X, Yu Y.
    Sleep Med; 2013 Jul 31; 14(7):662-7. PubMed ID: 23719477
    [Abstract] [Full Text] [Related]

  • 40. Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls.
    Carpenter LL, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH.
    Psychoneuroendocrinology; 2009 Sep 31; 34(8):1208-13. PubMed ID: 19375869
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.